RAPT THERAPEUTICS INC (RAPT) Stock Analyst Earnings Estimates
NASDAQ:RAPT - Nasdaq - US75382E1091 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.04M | 3.81M -24.40% | 1.53M -59.84% | -100.00% | 19.38M | 148.92M 668.42% | 244.8M 64.38% | 343.74M 40.42% | 447.78M 30.27% | 556.92M 24.37% | ||||
| EBITDA YoY % growth | -52.09M -23.14% | -68.21M -30.95% | -84.75M -24.25% | -129.458M -48.49% | -105.091M 16.49% | -77.194M 26.55% | -91.994M -19.17% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -53.21M -21.96% | -69.21M -30.07% | -85.8M -23.97% | -129.418M -48.09% | -104.512M 17.75% | -79.997M 23.46% | -84.425M -5.54% | -297.84M -252.78% | -217.26M 27.05% | -21.42M 90.14% | 128.52M 700.00% | 289.68M 125.40% | 438.6M 51.41% | |
| Operating Margin | -1,055.75% | -1,816.54% | -5,607.84% | N/A | N/A | N/A | N/A | -1,536.84% | -145.89% | -8.75% | 37.39% | 64.69% | 78.75% | |
| EPS YoY % growth | -2.19 5.62% | -2.53 -15.53% | -2.58 -1.98% | -3.17 -17.83% | -2.33 23.50% | -1.05 54.82% | -1.10 -4.85% | -4.14 -275.93% | -5.42 -30.79% | -0.53 90.21% | 3.17 698.08% | 7.11 124.12% | 10.71 50.65% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.38 52.06% | -0.12 85.15% | -0.12 82.76% | -0.14 70.70% | -0.14 62.77% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | -17.34M 45.81% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -19.429M 41.51% | -25.049M 25.35% | -25.22M 16.63% | -25.63M 3.61% | -26.041M -34.03% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.47 42.68% | -0.58 | 0.11 | 18.30% |
| Q2 2024 Q2Q % growth | -0.71 -7.58% | -0.73 | 0.02 | 3.32% |
| Q1 2024 Q2Q % growth | -0.79 -3.95% | -0.82 | 0.03 | 4.17% |
| Q4 2023 Q2Q % growth | -0.80 -25.00% | -0.88 | 0.08 | 8.68% |
| Q3 2023 Q2Q % growth | -0.82 -30.16% | -0.77 | -0.05 | -6.73% |
| Q2 2023 Q2Q % growth | -0.66 -6.45% | -0.80 | 0.14 | 17.22% |
| Q1 2023 Q2Q % growth | -0.76 -10.14% | -0.69 | -0.07 | -9.57% |
| Q4 2022 Q2Q % growth | -0.64 -4.92% | -0.67 | 0.03 | 4.06% |
| Q3 2022 Q2Q % growth | -0.63 | -0.68 | 0.05 | 7.81% |
| Q2 2022 Q2Q % growth | -0.62 1.59% | -0.77 | 0.15 | 18.95% |
| Q1 2022 Q2Q % growth | -0.69 -4.55% | -0.69 | 0.00 | 0.34% |
| Q4 2021 Q2Q % growth | -0.61 -17.31% | -0.67 | 0.06 | 8.99% |
| Q3 2021 Q2Q % growth | -0.63 -5.00% | -0.64 | 0.01 | 0.84% |
| Q2 2021 Q2Q % growth | -0.63 -23.53% | -0.68 | 0.05 | 7.54% |
| Q1 2021 Q2Q % growth | -0.66 -17.86% | -0.64 | -0.02 | -3.70% |
| Q4 2020 Q2Q % growth | -0.52 36.59% | -0.61 | 0.09 | 14.08% |
| Q3 2020 Q2Q % growth | -0.60 95.17% | -0.59 | -0.01 | -2.30% |
| Q2 2020 Q2Q % growth | -0.51 | -0.59 | 0.08 | 13.30% |
| Q1 2020 Q2Q % growth | -0.56 | -0.44 | -0.12 | -27.68% |
| Q4 2019 Q2Q % growth | -0.82 | -0.71 | -0.11 | -15.67% |
| Q3 2019 Q2Q % growth | -12.41 | -0.65 | -11.76 | -1,801.04% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | -100.00% | % | ||
| Q1 2023 Q2Q % growth | -100.00% | % | ||
| Q4 2022 Q2Q % growth | -100.00% | 221.003K | -221.003K | -100.00% |
| Q3 2022 Q2Q % growth | -100.00% | 343.883K | -343.883K | -100.00% |
| Q2 2022 Q2Q % growth | 890K 2.30% | 285.6K | 604.4K | 211.62% |
| Q1 2022 Q2Q % growth | 640K -47.54% | 229.5K | 410.5K | 178.87% |
| Q4 2021 Q2Q % growth | 760K -41.54% | 709.624K | 50.376K | 7.10% |
| Q3 2021 Q2Q % growth | 970K -36.60% | 793.897K | 176.103K | 22.18% |
| Q2 2021 Q2Q % growth | 870K -32.03% | 969K | -99K | -10.22% |
| Q1 2021 Q2Q % growth | 1.22M 29.79% | 926.16K | 293.84K | 31.73% |
| Q4 2020 Q2Q % growth | 1.3M | 1.302M | -2K | -0.15% |
| Q3 2020 Q2Q % growth | 1.53M | 1.021M | 509K | 49.85% |
| Q2 2020 Q2Q % growth | 1.28M | 1.005M | 275K | 27.36% |
| Q1 2020 Q2Q % growth | 940K | 4.25M | -3.31M | -77.88% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 8.21% | 10.24% |
| Revenue | N/A | N/A | N/A | N/A |